SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 124 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $973,595 | -66.1% | 67,052 | -51.1% | 0.00% | -71.4% |
| Q2 2023 | $2,870,591 | -48.4% | 137,152 | -47.9% | 0.01% | -50.0% |
| Q1 2023 | $5,561,994 | -31.2% | 263,352 | -17.1% | 0.01% | -39.1% |
| Q4 2022 | $8,089,333 | -9.4% | 317,852 | -14.5% | 0.02% | -11.5% |
| Q3 2022 | $8,933,000 | +31.6% | 371,752 | +5.4% | 0.03% | +36.8% |
| Q2 2022 | $6,789,000 | +6.0% | 352,852 | -4.2% | 0.02% | +11.8% |
| Q1 2022 | $6,402,000 | -17.5% | 368,352 | +3.9% | 0.02% | -10.5% |
| Q4 2021 | $7,761,000 | +18.8% | 354,552 | +3.7% | 0.02% | +11.8% |
| Q3 2021 | $6,533,000 | -11.2% | 341,852 | -20.2% | 0.02% | -10.5% |
| Q2 2021 | $7,357,000 | -43.4% | 428,452 | -26.4% | 0.02% | -47.2% |
| Q1 2021 | $13,008,000 | -12.4% | 581,752 | -12.9% | 0.04% | -10.0% |
| Q4 2020 | $14,846,000 | +288.2% | 667,552 | +157.7% | 0.04% | +263.6% |
| Q3 2020 | $3,824,000 | +28.7% | 259,052 | +29.2% | 0.01% | +22.2% |
| Q2 2020 | $2,972,000 | +425.1% | 200,552 | +289.0% | 0.01% | +350.0% |
| Q1 2020 | $566,000 | +87.4% | 51,552 | +49.6% | 0.00% | +100.0% |
| Q4 2019 | $302,000 | – | 34,452 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,600,000 | $52,272,000 | 8.55% |
| Foresite Capital Management IV, LLC | 875,000 | $12,705,000 | 7.06% |
| Aisling Capital Management LP | 1,025,000 | $14,883,000 | 6.13% |
| Saturn V Capital Management LP | 807,969 | $11,731,710 | 4.91% |
| Eversept Partners, LP | 2,596,245 | $37,697,477 | 3.19% |
| ACUTA CAPITAL PARTNERS, LLC | 297,035 | $4,312,948 | 2.89% |
| Paradigm Biocapital Advisors LP | 2,390,077 | $34,703,918 | 2.36% |
| DAFNA Capital Management LLC | 458,373 | $6,655,576 | 2.07% |
| SPHERA FUNDS MANAGEMENT LTD. | 773,061 | $11,224,846 | 2.04% |
| PFM Health Sciences, LP | 2,715,235 | $39,425,212 | 1.86% |